Evidence map›Paper›PMID 26031924›Full record

Trial reportJournal of autism and developmental disorders2015

Defining treatment response and symptom remission for anxiety disorders in pediatric autism spectrum disorders using the Pediatric Anxiety Rating Scale.

Carly J Johnco, Alessandro S De Nadai, Adam B Lewin, Jill Ehrenreich-May, Jeffrey J Wood, Eric A Storch

Erratum issuedAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of autism and developmental disorders, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Priority service needs and receipt across the lifespan for individuals with autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2017
    Article
  12. Article
  13. Treatment Concerns and Functional Impairment in Pediatric Anxiety.Child psychiatry and human development · 2016
    Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Carly J JohncoDepartment of Pediatrics, University of South Florida, St. Petersburg, FL, USA. cjohnco@health.usf.edu.ORCID http://orcid.org/0000-0002-2212-507X
Alessandro S De NadaiDepartment of Psychology, University of South Florida, Tampa, FL, USA.
Adam B LewinDepartment of Pediatrics, University of South Florida, St. Petersburg, FL, USA.
Jill Ehrenreich-MayDepartment of Psychology, University of Miami, Miami, FL, USA.
Jeffrey J WoodDivision of Child Psychiatry, University of California, Los Angeles, CA, USA.
Eric A StorchDepartment of Pediatrics, University of South Florida, St. Petersburg, FL, USA.
University of South Florida · USJohns Hopkins University · USUniversity of California, Los Angeles · USUniversity of Miami · USUniversity of South Florida St. Petersburg · US

Funding

1/3 CBT for Anxiety Disorders in Autism: Adapting Treatment for AdolescentsR34HD065270 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WOOD, JEFFREY JAMES · 2009 to 2010
$507k
2/3 CBT for Anxiety Disorders in Autism: Adapting Treatment for AdolescentsR34HD065274 · NICHD · UNIVERSITY OF SOUTH FLORIDA · PI STORCH, ERIC A. · 2009 to 2010
$423k
Alliance and Mechanisms of Medication Adherence in Pediatric Psychiatric PracticeF31MH094095 · NIMH · UNIVERSITY OF SOUTH FLORIDA · PI DE NADAI, ALESSANDRO STEVENS · 2013 to 2014
$69k
NICHD NIH HHS 1R34HD065274NICHD NIH HHS R34 HD065270NICHD NIH HHS R34 HD065274NIMH NIH HHS F31 MH094095
6 · The paper itself

Abstract

This study examined optimal guidelines to assess treatment response and remission for anxiety in youth with autism spectrum disorders (ASD) using the Pediatric Anxiety Rating Scale (PARS). Data was collected for 108 children aged 7-16 years with comorbid anxiety and ASD before and after receiving cognitive behavior therapy. Optimal cut-offs on the PARS were assessed using signal detection analyses using receiver operating characteristic methods. Maximum agreement with response criteria was achieved at 15 % reduction in symptoms on the PARS. Maximum agreement with remission criteria was achieved at 40 % reduction in symptoms, or at a score of 10 or below at post-treatment. Results have implications for standardizing criteria used in research trials and clinical practice.

Indexed as

Cognitive Behavioral TherapyAdolescentAnxiety DisordersAutism Spectrum DisorderChildFemaleHumansMaleAutismChildrenMeasurementPediatric Anxiety Rating ScaleTreatment

Identifiers

PMID26031924
PMCPMC4574290
OpenAlexW1499534675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.